WBR0392
| Author | [[PageAuthor::Rim Halaby, M.D. [1]]] |
|---|---|
| Exam Type | ExamType::USMLE Step 1 |
| Main Category | MainCategory::Pharmacology |
| Sub Category | SubCategory::Infectious Disease |
| Prompt | [[Prompt::A 35 year old man previously diagnosed with HIV presents to the infectious disease clinic at a local hospital for a regular follow-up. Although he was not treated, his last CD4 count 3 months ago was 670 cells/mm3 and his viral load was low to undetectable. In the past month, the patient was admitted twice to the hospital for a community acquired pneumonia and a gastroenteritis. His new tests show a CD4 of 231 cells/mm3 and a viral load of 325000 copies/ml. The infectious disease physician decides to initiate highly active antiretroviral therapy (HAART) in this patient given the recent findings. Which of the following drug regimens are suitable?]] |
| Answer A | AnswerA::Tenofovir + emtricitabine + abacavir |
| Answer A Explanation | AnswerAExp:: |
| Answer B | AnswerB::Darunavir + raltegravir + Lamivudine |
| Answer B Explanation | AnswerBExp:: |
| Answer C | AnswerC::Efavirenz + tenofovir + nevirapine |
| Answer C Explanation | AnswerCExp:: |
| Answer D | AnswerD::Ritonavir + tenofovir + lopinavir |
| Answer D Explanation | AnswerDExp:: |
| Answer E | AnswerE::Raltegravir + tenofovir + emtricitabine |
| Answer E Explanation | AnswerEExp:: |
| Right Answer | RightAnswer::E |
| Explanation | [[Explanation:: Educational Objective: |
| Approved | Approved::No |
| Keyword | WBRKeyword::HAART therapy, WBRKeyword::HIV, WBRKeyword::AIDS, WBRKeyword::CD4 count, WBRKeyword::HIV drug combinations |
| Linked Question | Linked:: |
| Order in Linked Questions | LinkedOrder:: |